trump glp 1 announcement Weight-loss drug makers announce pricing agreement with Questions swirl after Trump's GLP-1
Description
Overall, the GLP-1 market is expected to experience annual growth exceeding 20% and will hit $133 billion worldwide by 2030, according to a MarketWatch report from February.
Background In idiopathic intracranial hypertension (IIH), sustained weight loss is the main pillar in modifying disease course, whereby glucagon-like peptide-1 receptor agonists (GLP-1-RAs) could present an attractive treatment option
Incretin mimetics considerably expanded their proven benefits beyond obesity in 2024
All Day
Standards of Care in Diabetes2025
Rheumatology insights & real results.
